The Association for Molecular Pathology announced the publication of best practice recommendations for clinical laboratories developing and performing homologous recombination deficiency (HRD) testing ...

The Association for Molecular Pathology, the premier global molecular diagnostic professional society, today announced the publication of best practice recommendations for clinical laboratories ...

NEW YORK – The Association for Molecular Pathology on Tuesday published best practice recommendations for the design and validation of clinical tests for homologous recombination deficiency. The ...

Pathology testing is crucial for Australians to remain healthy, with their first test happening just minutes after they are born. And while many Aussies delay or avoid these tests until they have ...

a leading innovator in clinical diagnostics, today announced a collaboration with Phanes Biotech to co-develop a blood-based Alzheimer’s disease (AD) tau pathology test. Phanes Biotech is an ...

is the first FDA cleared blood-based IVD test in the U.S. to aid to identify patients with amyloid pathology associated with Alzheimer’s Disease (AD). Alzheimer’s disease currently affects an ...

A clinical diagnostics company and biotech firm have announced a partnership to develop a blood-based tau pathology test that would assist in the diagnosis of Alzheimer’s disease. In a press ...

A study from PreciseDx showed that its artificial-intelligence-guided pathology test could help predict a patient’s chances of their breast cancer returning on par with a leading genomic approach.

Three large pathology companies, Ampath, PathCare and Lancet Laboratories, yesterday denied before the Competition Tribunal that they had charged excessive prices for COVID-19 PCR tests and ...

Measuring that form, called ptau-217, was found to give the most accurate assessment of Alzheimer’s pathology in a comparison of various Alzheimer’s blood tests that will also be presented at ...